LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 38 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $18,000 | +80.0% | 2,200 | 0.0% | 0.00% | – |
Q1 2020 | $10,000 | -33.3% | 2,200 | 0.0% | 0.00% | – |
Q4 2019 | $15,000 | -67.4% | 2,200 | -50.0% | 0.00% | – |
Q3 2019 | $46,000 | +64.3% | 4,400 | +100.0% | 0.00% | – |
Q2 2019 | $28,000 | +33.3% | 2,200 | 0.0% | 0.00% | – |
Q1 2019 | $21,000 | -4.5% | 2,200 | 0.0% | 0.00% | – |
Q4 2018 | $22,000 | – | 2,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 500,000 | $2,470,000 | 0.65% |
Orbimed Advisors | 6,466,783 | $31,946,000 | 0.54% |
SAMLYN CAPITAL, LLC | 798,566 | $3,945,000 | 0.10% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 915,355 | $4,522,000 | 0.01% |
IHT Wealth Management, LLC | 11,660 | $58,000 | 0.01% |
FIDUCIARY TRUST CO | 37,998 | $188,000 | 0.01% |
FRANKLIN RESOURCES INC | 700,000 | $3,458,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 13,700 | $68,000 | 0.00% |
Tower Research Capital LLC (TRC) | 2,249 | $11,000 | 0.00% |
MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |